Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
AstraZeneca Invests $1.5 Billion to Construct Antibody Drug Conjugate Facility in Singapore
AstraZeneca has announced a significant investment of $15 billion to establish a stateoftheart manufacturing facility in Singapore, dedicated to the production of AntibodyDrug Conjugates ADCs This facility will play a pivotal role in advancing the companys efforts to deliver cuttingedge cancer treatments
Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.
Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization
Piramal Pharma Invests $80 Million to Expand Sterile Injectable Facility in Kentucky
Piramal Pharma Solutions PPS is investing $80M to expand its Lexington, Kentucky facility This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization The expansion will support PPSs ADCelerate
AstraZeneca Invests $3.5 Billion to Expand R&D and Manufacturing in the U.S
AstraZeneca has unveiled plans for a $35 billion capital investment in the United States to enhance its research and manufacturing capabilities This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand highskilled jobs, bolstering
Grünenthal Invests €80 Million to Enhance Latin American Production
Grnenthal, a prominent pharmaceutical company specializing in pain management and research, has announced a significant investment in its Latin American production facilities, exceeding 80 million
Kyowa Kirin Plans $530 Million Investment for New Biologics Manufacturing Plant in North Carolina
Kyowa Kirin, Inc, a global specialty pharmaceutical company headquartered in Japan, has announced plans to invest up to $530 million in building a new manufacturing facility in Sanford, North Carolina
Merck Invests €62 Million in New Quality Control Center in Germany
Merck, a leading science and technology company, is investing 62 million in a new quality control facility for its Life Science division at its Darmstadt headquarters
AstraZeneca's $1.5B Investment in Singapore for Antibody Drug Conjugates
AstraZeneca has announced plans to invest $15 billion in a new manufacturing facility in Singapore dedicated to antibodydrug conjugates
AbbVie Invests €150 Million in New Research and Development Facility in Germany
AbbVie has initiated the construction of its new central research facility, LUnA, at its main campus in Ludwigshafen, RhinelandPalatinate, Germany
€80 Million Investment by GEA to Enhance Pharmaceutical Standards at Elsdorf Factory
GEA has announced a substantial investment of 80 million to enhance pharmaceutical production standards at its Elsdorf factory, aiming to modernize facilities and improve operational efficiency
